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It has been known since the 1950s that envi-
ronmental chemicals are present in breast
milk (1), but this issue has gained attention
over the past few years. For example, the U. S.
Environmental Protection Agency (U.S.
EPA) noted that indicators of potentially high
childhood chemical exposure include chemi-
cals in breast milk and proposed chemicals in
breast milk as candidates for testing under the
Children’s Health Chemical Testing Program
(2,3). In an address to the National Women’s
Health Leadership Summit, the U.S. EPA (4)
announced that they had 
set tougher new standards for burning municipal
waste—one of the largest sources of dioxin, which
accumulates in human tissue and breast milk.…
Further, the Endocrine Disruptor Screening
and Testing Advisory Committee recom-
mended that the U.S. EPA screen and
potentially test “representative mixtures to
which large … segments of the population
are exposed,” including breast milk (5).
Groups advocating for women’s and chil-
dren’s health have also focused on chemicals
in breast milk (6,7).
Although research has provided informa-
tion on the types of chemicals likely to be
found in breast milk and on the toxicologic
aspects of many of these chemicals, there are
few data on parameters related to infant expo-
sure via breast-feeding, including those with a
time-dependent nature. This type of informa-
tion is necessary for performing exposure
assessments without heavy reliance on default
assumptions or on the limited databases cur-
rently available. In addition, data collected
longitudinally provide information on trends
in breast milk chemical levels, which indicate
whether controls on sources of contaminants
are effective. Without this type of informa-
tion, it will continue to be difﬁcult to provide
a scientiﬁcally based and consistent message
to interested parties (e.g., doctors, nurses, lac-
tation specialists, and new mothers) on the
risks and benefits of breast-feeding and to
compare these to formula-feeding. 
In this paper, we review the extant data
on two of the parameters needed to conduct
realistic exposure assessments for breast-feed-
ing infants, the ﬁrst step in risk/beneﬁt analy-
ses and subsequent formulation of risk/beneﬁt
messages. In particular, we focus on what is
known about the levels of chemicals in
human milk in the United States and the
elimination kinetics (depuration) of chemicals
from the mother during breast-feeding.
Information on, and uncertainties associated
with, other breast-feeding–related parameters
have been discussed elsewhere (8).
Levels and Trends of
Environmental Chemicals 
in Breast Milk in the United
States
Chlorinated organic pesticides, polychlori-
nated biphenyls (PCBs), and polychlorinated
dioxins and furans have been the focus of the
majority of studies on environmental chemi-
cals in breast milk. We describe the database
of published studies of these chemicals in
breast milk in the United States and use this
database of dioxin and furan concentrations
in breast milk to explore whether any trends
in concentrations of environmental chemicals
(from selected countries and the United
States) can be discerned. The discussion on
trends is limited to dioxins, which have been
examined more fully than most other chemi-
cals [with the possible exception of trichloro-
bis(p-chlorophenyl)ethane (DDT) and its
metabolites, reviewed by Smith (9)].
Levels
Figure 1 presents data on concentrations of
organochlorine pesticides in breast milk from
the United States, plotted by year [pre-1986
data: Jensen and Slorach (10); post-1985
data: Kostyniak et al. (11), Jensen and Slorach
(10), Mattison et al. (12)]; data for DDT and
metabolites reviewed by Smith (9) have not
been included. Figure 2 shows PCB data for
breast milk from the United States [pre-1986
data: Jensen and Slorach (10); post-1985
data: Hong et al. (13), Kostyniak et al. (11),
Mattison et al. (12)]. Data normalized by
lipid level (milligrams per kilogram, lipid
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The presence of environmental chemicals in breast milk has gained increased attention from regu-
latory agencies and groups advocating women’s and children’s health. As the published literature
on chemicals in breast milk has grown, there remains a paucity of data on parameters related to
infant exposure via breast-feeding, particularly those with a time-dependent nature. This informa-
tion is necessary for performing exposure assessments without heavy reliance on default assump-
tions. Although most experts agree that, except in unusual situations, breast-feeding is the
preferred nutrition, a better understanding of an infant’s level of exposure to environmental
chemicals is essential, particularly in the United States where information is sparse. In this paper,
we review extant data on two parameters needed to conduct realistic exposure assessments for
breast-fed infants: a) levels of chemicals in human milk in the United States (and trends for diox-
ins/furans); and b) elimination kinetics (depuration) of chemicals from the mother during breast-
feeding. The limitations of the existing data restrict our ability to predict infant body burdens of
these chemicals from breast-feeding. Although the data indicate a decrease in breast milk dioxin
toxic equivalents over time for several countries, the results for the United States are ambiguous.
Whereas available information supports the inclusion of depuration when estimating exposures
from breast-feeding, the data do not support selection of a speciﬁc rate of depuration. A program
of breast milk monitoring would serve to provide the information needed to assess infant expo-
sures during breast-feeding and develop scientiﬁcally sound information on beneﬁts and risks of
breast-feeding in the United States. Key words: breast milk, chlorinated organic chemicals, depu-
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Reviewbasis) were included in Figures 1 and 2. For
studies that collected data over more than 1
year, either the midpoint (for a range of
more than 2 years) or the ﬁrst year was plot-
ted. Information on dioxins and furans in
breast milk in the United States is shown in
Figure 3. 
Given the signiﬁcant restrictions on man-
ufacture, use, or release of the chemicals
shown in Figures 1–3, it is unlikely that pre-
1985 data are representative of current breast
milk levels. Focusing on data from 1985 for-
ward, the largest databases in the United
States are for PCBs and dioxins/furans
(Figures 2 and 3). The PCB data derive from
studies of women residing in New York [98
donors, Kostyniak et al. (11); 50 donors,
Hong et al. (13)] and Arkansas [942 donors,
Mattison et al. (12)]. The dioxin data are
derived from breast milk samples from
women residing in Binghamton, New York
[22 samples pooled to one sample, World
Health Organization (WHO) (14); Schecter
et al. (15)], Los Angeles, California [21
donors pooled to one sample, WHO (14)],
Los Angeles County [24 donors pooled, as
cited in Jensen and Slorach (10)]; and
Tennessee [nine donors pooled to one sam-
ple, Schecter et al. (16)].
Because the data describing levels of
environmental chemicals in breast milk from
women residing in the United States are geo-
graphically limited and from generally small
populations, they cannot be considered rep-
resentative of current breast milk levels of
women in the United States in general. 
Trends
Because of worldwide attention on diox-
ins/furans and their reduced release into the
environment, it is expected that breast milk
levels would be declining in the United
States. The analysis presented here suggests
that this is the case for many countries. The
international databases on dioxins/furans in
breast milk were used to explore the extent of
breast milk dioxin data and to determine
whether any trends in concentrations over
time are evident (Table 1). Breast milk data
were collected for the years 1970–1998 from
published sources. Data were available from
the following countries: Austria, Belgium,
Canada, Denmark, Finland, Germany,
Hungary, Japan, the Netherlands, Norway,
Pakistan, Spain, Sweden, United Kingdom,
United States, the former Soviet Union,
Ukraine, and Yugoslavia. Extremely limited
data or data for one year only were available
from the following countries: Albania, China,
Croatia, Czech Republic, France, India, Italy,
Kazakhstan, Lithuania, New Zealand,
Poland, Russia, Slovak, South Africa, and
Thailand. For breast milk samples collected
before 1989, we used a combination of data
from a compilation by Jensen and Slorach
(10) and primary literature. For breast milk
samples collected after 1988, data were all
from primary literature. We assembled the
following information: date, country, number
of donors, dioxin and furan congener concen-
tration, toxic equivalency factors (TEF) value,
percent lipid, description of sampling loca-
tion/population, and reference; not all infor-
mation was available for each sample. We
calculated total toxic equivalents (TEQs) for
dioxins and furans combined. For the pur-
poses of this paper, “dioxin TEQs” refer to
dioxin and furan TEQs combined. We used
international TEF (I-TEF) values and WHO
TEF values (Table 2) to calculate the TEQs
of the dioxins and furans in breast milk (our
values are based on I-TEF values). 
Because sampling and analysis protocols
can substantially impact the results of a
breast milk sampling program and because
the data assessed in this analysis derive from
studies conducted with varied protocols, the
comparability of study results is questionable.
For example, variation in the time of breast
milk sampling (including time postpartum
and time of day), the age of the mother, and
the number of previously breast-fed children
can produce inconsistent interstudy results.
In addition, most countries lack adequate
numbers of breast milk samples for the data
to be considered representative of the entire
country. Regardless, the data assembled here
represent the preponderance of published
data on dioxin in breast milk. 
Uncertainties in the breast milk dioxin
database, in addition to those mentioned
above, impact its usefulness in ascertaining
trends in data over time. We describe some of
the shortcomings of the reported data below. 
Date of sampling. In many cases, the
actual year that breast milk sampling was
conducted was not provided. In these
instances, we used the year of publication for
the sake of consistency. However, this clearly
biases the time frame of sampling (which
was likely to have occurred from 1 to several
years before publication) and increases
uncertainty in the time-trend analysis. This
is particularly important because the prepon-
derance of the data span approximately 15
years; uncertainty regarding the sampling
year can clearly impact the results. 
In some cases, sampling occurred over a
period of more than 1 year. For the purposes
of this analysis, if the sampling time frame
was 2 years, we used the earlier reported year.
If the sampling time frame was > 2 years, we
used the midpoint in time. 
Congener concentration measurements.
In some cases, study authors did not report
data for each specific congener, but rather
provided summations of certain congeners,
particularly for the 2,3,7,8-pentachlorinated
dibenzofurans. For these congeners, we used
the more conservative TEF of 0.5. Non-
reported congeners were considered to have
a value of zero. For data reported as “nonde-
tect,” and for which detection limits were
provided, we used the detection limit as the
concentration value. 
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Figure 1. Concentrations of environmental chemi-
cals (organochlorine pesticides and metabolites)
in breast milk from the United States (ppm, lipid
basis). Abbreviations: HCB, hexachlorobenzene;
HCH, hexachlorocyclohexane. DDT and metabo-
lites are not shown. Pre-1985 data from Jensen
and Slorach (10); data post-1985 from Kostyniak et
al. (11), Jensen and Slorach (10), and Mattison et
al. (12).
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Figure 2. Concentrations of PCBs in breast milk
from the United States (ppm, lipid basis) Pre-1985
data from Jensen and Slorach (10); data post-1985
from Hong et al. (13), Kostyniak et al. (11), and
Mattison et al. (12).
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Figure 3. Dioxins/furans in breast milk (ppt TEQ,
lipid basis) for the United States and Canada.
Data from Table 1 I-TEF values.
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CanadaMeasure of central tendency. Because the
dioxin breast milk concentrations are not nec-
essarily normally distributed, the median, geo-
metric mean, or other statistic might be the
preferred measure of central tendency (9). In
addition, it is not clear that central tendency is
of primary interest; for example, frequencies of
extreme (high or low) concentrations may be
more important. However, the arithmetic
mean was the most commonly reported mea-
sure; thus, for consistency, we used arithmetic
means in this analysis. 
Sources of variability. Most samples rep-
resent a different number of donors (due to
pooling). In addition, a certain amount of
laboratory variability is associated with the
analytical results of each sample. Thus, the
samples have different inherent variability;
therefore, care is required in interpreting
apparent trends. 
The results of this analysis indicate an
international decline in concentration of
dioxin in breast milk over time (Figure 4).
High levels of dioxin TEQs in breast milk
from the early 1970s are from mothers resid-
ing in areas in Vietnam that had been
sprayed with Agent Orange, a defoliant cont-
aminated with dioxins, during the Vietnam
war. If we focus on the data from the 1980s
and 1990s, it is more difficult to discern a
trend in breast milk dioxin levels. This is
likely due, in part, to the general paucity of
data and the uncertainties in the database
described above. By examining the data from
each country individually, a clearer picture
emerges. Breast milk dioxin data from several
countries seem to suggest a decline in levels
over time (including Austria, Belgium,
Denmark, Finland, Germany, Hungary,
Japan, the Netherlands, Norway, Pakistan,
Sweden (42), the United Kingdom, Ukraine,
Vietnam, and Yugoslavia); Figure 5 shows
Children’s Health • Infant exposure to chemicals in breast milk
Environmental Health Perspectives • VOLUME 109 | NUMBER 1 | January 2001 77
Table 1. Compilation of published international data on dioxin TEQs in breast milk. 
No. donors Dioxin TEQs: I-TEF Dioxin TEQs: WHO-TEF
Year Country /samplesa Location (description) Reference (ppt, lipid basis) (ppt, lipid basis)
1992 Albania 10/1 Tirana (17)b  4.8 –
1992 Albania 10/1 Librazhd (17) 3.8 –
1986 Austria 54/1 Vienna (14)c  17.7 19.7
1986 Austria 51/1 Tulln (14) 19.3 21.8
1992 Austria 13/1 Vienna (urban) (17) 10.7 –
1992 Austria 21/1 Tulln (rural) (17) 10.9 –
1992 Austria 13/1 Brixlegg (industrial) (17) 14.0 –
1987 Belgium 1 Rural (14) 34.4 39.1
1987 Belgium 1 Industrial (14) 41.5 46.6
1987 Belgium 1 Urban (14) 39.3 43.6
1992 Belgium 9 5 Flemish provinces (18) 35.0 40.7
1992 Belgium 8/1 Brabant Wallou (17) 20.8 –
1992 Belgium 20/1 Liege (17) 27.1 –
1992 Belgium 6/1 Brussels (17) 26.6 –
1981 Canada 200/1d Whole country (19) 24.7 29.3
1986 Canada 100e  Whole country (19) 15.1 18.0
1987 Canada 19/1 Maritime (14) 16.2 19.0
1987 Canada 34/1 Québec (14) 18.9 22.8
1987 Canada 32/1 Ontario (north and east) (14) 17.4 20.5
1987 Canada 44/1 Ontario (Toronto and southwest) (14) 18.4 21.9
1987 Canada 31/1 Prairies (14) 19.8 23.7
1987 Canada 23/1 British Columbia (14) 24.0 28.9
1989 Canada 105f Northern Québec (20) 19.2 –
1989 Canada 96f Southern Québec (20) 13.3 –
1992 Canada 20/1 Maritimes (17) 11.0 –
1992 Canada 20/1 Québec (17) 13.6 –
1992 Canada 20/1 Ontario (17) 18.3 –
1992 Canada 20/1 Prairies (17) 14.8 –
1992 Canada 20/1 British Columbia (17) 15.8 –
1992 Canada 100/1 All provinces (17) 14.6 –
1992 Canada 12/1 Gaspe (17) 23.4 –
1992 Canada 4/1 Basse Côte-Nord (17) 14.7 –
1992 Canada 4/1 Ungave Bay (17) 14.5 –
1992 Canada 5/1 Hudson Bay (17) 21.1 –
1994 China 50/1 Rural (21) 2.7 3.1
1992 Croatia 10/1 Krk (17) 8.4 –
1992 Croatia 13/1 Zagreb (17) 13.5 –
1992 Czech Republic 11/1 Kladno (17,22) 12.4 13.3
1992 Czech Republic 11/1 Uherské Hradis ˘tìe ˘( 17,22) 18.5 20.0
1985 Denmark 2 Copenhagen (10) 69.3 84.0
1986 Denmark 10g NP (14) 17.6 20.2
1986 Denmark 42/1 NP (14) 17.7 20.6
1992 Denmark 48/1 7 different cities (17) 15.2 –
1991 East Germany 499f 17 regions of former GDR (23) 23.2 27.5
1987 Finland 38/1 Helsinki (14) 18.1 20.8
1987 Finland 31/1 Kuopio (14) 15.8 18.5
1987 Finland 37 Kuopio (24) 20.1 –
1987 Finland 47 Helsinki (24) 26.3 –
1992 Finland 10/1 Helsinki (17) 21.5 –
1992 Finland 24/1 Kuopio (17) 12.0 –
1993 Finland 28 Kuopio (24) 13.6 –
1993 Finland 14 Helsinki (24) 19.9 -
continued, next pagedata for Germany, Norway (for ease of
graphing, one value > 100 ppt in 1985 was
omitted), the Netherlands, and Japan.
[Norén and Lundén (42) observed a decline
in dioxin and furan levels in breast milk from
mothers in the Stockholm region from 1972
to 1985. Between 1985 and 1989, however,
they reported that this trend did not con-
tinue. The European Union data for Sweden
reported for the early 1990s also suggested a
plateau in the dioxin levels (see data for
Sweden in Table 1).] 
Germany, with its rich database, seems
to provide the most compelling evidence for
a decline in breast milk dioxin levels over
time (43,44). For example, Fürst and
Wilmers (43), in their analysis of approxi-
mately 1,000 breast milk samples from
North Rhine-Westphalia, reported that
dioxin TEQ levels decreased from 34 ppt
(lipid based) in 1989 to 14.2 ppt in 1996,
about a 60% decline. The data for Japan
(30), Norway, and the United Kingdom also
provide convincing evidence for a decrease
in breast milk dioxin levels. Iida et al. (30)
reported a slight decline in PCDD TEQs in
breast milk from 1994 to 1996; their data
are not aggregated (i.e., dioxin and furan
data were not combined) and their assess-
ment did not include dioxin data from the
1980s. The data from Canada, the Czech
Republic, France, Spain, and the United
States are more ambiguous, whereas those
from Italy and Lithuania suggest an increase
in dioxin levels in breast milk. Craan and
Haines (45) summarized Canadian breast
milk data collected over 25 years by Health
Canada, including data for dioxin, and
reported the following decline in dioxin
TEQs (ppt, lipid basis): 24.7 ppt for
1981–1982; 15.6 ppt for 1986–1987; and
14.5 ppt for 1992. For Canada (Figure 3),
the decline indicated by the data reported by
Craan and Haines (45) is obscured by addi-
tional province-specific data reported by
Children’s Health • LaKind et al.
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Table 1. Continued
No. donors Dioxin TEQs: I-TEF Dioxin TEQs: WHO-TEF
Year Country /samplesa Location (description) Reference (ppt, lipid basis) (ppt, lipid basis)
1990 France 15 Paris (25,26) 20.3 23.4
1992 Germany 56 Northrhine-Westphalia (24) 20.5 –
1992 Germany 10/1 Berlin (17) 16.6 –
1993 Germany 78 Northrhine-Westphalia (24) 20.9 –
1994 Germany 50 Northrhine-Westphalia (24) 17.2 –
1995 Germany 38 Northrhine-Westphalia (24) 16.1 –
1996 Germany 22 Northrhine-Westphalia (24) 14.1 –
1997 Germany 9 Northrhine-Westphalia (24) 12.0 –
1984 Germany, FRG 5f NP (10) 33.1 39.2
1984 Germany, FRG 94f Münster (10) 30.5 35.8
1985 Germany, FRG 193f Northrhine-Westphalia (14) 27.9 32.7
1985 Germany, FRG 79 Northrhine-Westphalia (14) 32.0 37.7
1985 Germany, FRG 30g West Berlin (10) 32.0 39.0
1987 Germany, FRG 35d Oldenburg (14) 35.8 39.1
1987 Germany, FRG 40/1 West Berlin (14) 32.4 39.1
1987 Germany, FRG 35f West Berlin (14) 33.4 40.5
1987 Germany, FRG 23/1 Recklinghausen (14) 33.2 40.0
1987 Germany, FRG 10f Recklinghausen (14) 30.9 36.7
1987 Germany, FRG 14f Weiden (14) 30.6 36.4
1987 Germany, FRG 9f Rheinfelden (14) 37.4 45.0
1987 Germany, FRG 6f Flensburg (14) 31.9 37.7
1987 Hungary 100/1 Budapest (14) 9.6 9.9
1987 Hungary 50/1 Szentes (14) 11.8 12.3
1992 Hungary 20/1 Budapest (17) 8.6 –
1992 Hungary 10/1 Scentes (17) 7.8 –
1987 India 7/1 Bombay (14) 6.7 7.2
1976 Italy 3g Seveso (10) 13.0 13.0
1987 Italy 9/1 Pavia (27) 31.5 36.4
1987 Italy 9/1 Rome (27) 21.8 25.3
1987 Italy 27/1 Florence (27) 28.8 33.6
1987 Italy 14/1 Milan (27) 18.8 21.0
1980 Japan 265/7 Osaka (10) 50.9 57.7
1987 Japan 3/1 Fukuoka Prefecture (14) 21.2 22.4
1987 Japan 3/1 Fukuoka Prefecture (14) 27.4 29.0
1991 Japan 9  NP in English (28) 13.6 16.4
1994 Japan 15 Fukuoka (29) 15.6 18.8
1995 Japan 51 Western Japan (30) 18.0 21.8
1995 Japan 44 Western Japan (30) 13.2 15.7
1996 Kazakhstan 97/40 NP (31) 20.5 22.6
1992 Lithuania 12/1 Palanga (coastal) (17) 16.6 –
1992 Lithuania 12/1 Anykshchiai (rural) (17) 14.4 –
1992 Lithuania 12/1 Vilnius city (urban) (17) 13.3 –
1993 Lithuania 12/1 Palanga (coastal) (32) 16.9 18.5
1993 Lithuania 12/1 Anykshchiai (rural) (32) 14.6 16.4
1993 Lithuania 12/1 Vilnius (urban) (32) 13.8 15.1
1985 Netherlands 3g NP (10) 110.0 131.3
1985 Netherlands 18g Amsterdam (10) 43.1 57.2
1987 Netherlands 13/1 Urban (14) 37.8 45.8
1987 Netherlands 13/1 Rural (14) 40.0 48.4
1988 Netherlands 10 pools of  All regions (24)h 34.2 –
10 samples
continued, next pageLiem et al. (17). A smoothed fit (least
squares) through the data for the Western
European countries also suggests an overall
decline (Figure 6). In contrast, Figure 3,
which includes dioxin/furan data for the
United States, reveals the limit of our knowl-
edge of what constitutes a “representative”
level of dioxins/furans in U.S. breast milk
and whether levels in the United States are
declining.
In summary, for many of the countries
for which dioxin TEQs in breast milk have
been reported, the data indicate a decrease in
breast milk dioxin TEQs over time. For
countries with ambiguous results, including
the United States, it is possible that an
improved database (e.g., greater number of
samples collected over time from a broader
geographic area with appropriate sampling
and analysis protocols) might reveal similar
future reductions in breast milk dioxin
TEQs. 
Generally speaking, extremely limited
data on organic environmental chemicals in
breast milk in the Unites States have been
reported in the published literature. In fact,
as reported by Hooper (46), “…more is
known about the breast milk contamination
and body burdens of the mother, infant, and
child living in Ukraine or Kazakhstan than,
for example, about similar groups living in
California.” Further, the limited data avail-
able in the United States do not provide
information on chemicals that are only now
beginning to receive attention [e.g., poly-
brominated biphenyl ethers (47)]. Although
we can draw inferences from breast milk
data from other countries, the paucity of
breast milk data for the United States limits
the conﬁdence in our ability to assess infants’
exposures, risks, and benefits from breast-
feeding, to compare these risks and beneﬁts
to formula feeding, and to reach conclusions
about the effectiveness of contaminant
source controls. 
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Table 1. Continued
No. donors Dioxin TEQs: I-TEF Dioxin TEQs: WHO-TEF
Year Country /samplesa Location (description) Reference (ppt, lipid basis) (ppt, lipid basis)
1991 Netherlands 209 Groningen/Rotterdam (33) 28.7 33.2
1992 Netherlands 168 Rotterdam/Groningen (24) 30.0 –
1992 Netherlands 176 Rotterdam/Groningen (24) 30.2 –
1992 Netherlands 17/1 Whole country (17) 22.5 –
1993 Netherlands 103 All regions (24) 23.5 –
1998 Netherlands 10 pools of  All regions (24) 34.2 –
9–13 samples 
1987 New Zealand 2 Auckland (14) 6.4 7.6
1987 New Zealand 20f Christchurch, Auckland (34) 16.5 19.7
1987 New Zealand 17f Canterbury, Northland (34) 18.1 21.9
1986 Norway 11f Tromsø (14) 16.1 18.3
1986 Norway 10f Hamar (14) 15.2 17.4
1986 Norway 10f Skien/Porsgrunn (14) 19.8 22.3
1992 Norway 10/1 Hamar (rural) (32) 9.5 10.8
1992 Norway 10/1 Tromsø (coastal) (32) 10.3 11.8
1993 Norway 10/1 Skien/Porsgrunn (industrial) (32) 12.8 14.6
1990 Pakistan 7/1 Karachi (16) 15.2 17.7
1992 Pakistan 14/1 Lahore (17) 3.9 –
1986 Poland 5f Bytom (14) 23.0 25.8
1992 Russia 1 Arkhankelsk (17) 15.2 –
1992 Russia 1 Karhopol (17) 5.9 –
1992 Slovak 10/1 Michalovce (17) 15.2 –
1992 Slovak 10/1 Nitra (17) 12.6 –
1990 South Africa 6/1 NP (16) 8.5 10.2
1990 South Africa 18/1 NP (16) 12.9 15.5
1990 Spain 13 Madrid (25,26) 13.3 17.7
1992 Spain 19/1 Bizkaia (17) 19.4 –
1992 Spain 10/1 Gipuzkoa (17) 25.5 –
1996 Spain 15/1 Tarragona (35) 12.0 13.9
1972 Sweden 227/4 Stockholm (10) 33.7 37.8
1976 Sweden 245/4 Stockholm (10) 30.2 33.4
1980 Sweden 340/4 Stockholm (10) 19.8 22.5
1984 Sweden 102/2 Stockholm (36) 15.0 -
1984 Sweden 4f Umeå (10) 21.1 24.1
1987 Sweden 10f Sundsvall (14) 22.6 26.3
1987 Sweden 10f Gothenburg (14) 22.8 26.3
1987 Sweden 10f Uppsala (14) 22.4 25.8
1987 Sweden 10f Borlänge (14) 20.4 23.5
1990 Sweden 60/3 Stockholm (36)i 17.0 –
1991 Sweden 60/3 Stockholm (36)i 13.0 –
1992 Sweden 40/2 Stockholm (36)i 18.0 –
1987 Thailand 3/1 Bangkok (14) 5.2 6.2
1987 United Kingdom 20/1 Birmingham (37) 37.2 43.9
1987 United Kingdom 20/1 Glasgow (37) 29.1 34.9
1988 United Kingdom 40 Birmingham (24)h 37.0 –
1988 United Kingdom 40 Glasgow (24)h 29.1 –
1989 United Kingdom ?/2 Wales (24) 33.0 39.2
1992 United Kingdom 20/1 Birmingham (17) 17.9 –
1992 United Kingdom 23/1 Glasgow (17) 15.2 –
1993 United Kingdom 20/1 Birmingham (37) 21.0 25.3
1993 United Kingdom 20/1 Glasgow (37) 21.0 25.2
continued, next pageDepuration of Environmental
Chemicals from Breast Milk
during Lactation
The typical procedure for estimating intakes
of environmental chemicals by nursing
infants involves selecting a daily volume of
breast milk consumed (typically approxi-
mately 800 mL/day) and multiplying this
value by an empirical or modeled concentra-
tion of a chemical in breast milk. The advan-
tage to this approach is the simplicity of the
computation. However, the limitations are
clear—these estimates do not account for
variability in exposure, and more importantly,
there is no recognition that a woman’s stores
of lipophilic chemicals in adipose tissue and
breast milk are depleted over the duration of
lactation. In fact, the depuration of chemicals
due to breast-feeding is a critical, yet poorly
characterized, parameter in evaluating infant
exposure to chemicals in breast milk (8). It is
not clear which factors may inﬂuence elimina-
tion kinetics; for example, it is likely that
some of the following would inﬂuence depu-
ration: initial chemical concentration, age of
the mother, parity, volume of milk consumed
by infant, supplementation with formula or
solid foods, and properties of individual
chemicals.
A few previous efforts to model concen-
trations of lipophilic compounds in breast
milk have incorporated the depuration
process by estimating the decline in chemical
concentration over the duration of breast-
feeding. For example, LaKind et al. (8)
incorporated depuration rates of 30, 50, or
70% over 6 months for 2,3,7,8-TCDD.
Patandin et al. (48) used a 20% decrease in
dioxin/PCB body burden of the breast-feed-
ing mother to calculate a weekly decrease of
1.7% in dioxin/PCB concentration in breast
milk (modeled as o∫ Te–0.017t dt). Sullivan et
al. (49) modeled the decrease in dioxin in
breast milk as first order elimination.
Kreuzer et al. (50) reported a good correla-
tion between modeled and published values
of TCDD in mother’s milk by assuming an
approximately 70% decline in the levels of
TCDD in milk after 6 months of daily
breast-feeding. 
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Table 1. Continued
No. donors Dioxin TEQs: I-TEF Dioxin TEQs: WHO-TEF
Year Country /samplesa Location (description) Reference (ppt, lipid basis) (ppt, lipid basis)
1993 United Kingdom 20/1 Cambridge (37) 23.8 28.6
1992 Ukraine 5/1 Kiev no. 1 (17) 11.0 –
1992 Ukraine 5/1 Kiev no. 2 (17) 13.3 –
1993 Ukraine 50/1 Dniprodzerzhinsk (38) 8.1 9.2
1993 Ukraine 50/1 Dniprodzerzhinsk (38) 11.7 13.2
1993 Ukraine 51/1 Kyiv (38) 8.0 9.0
1993 Ukraine 49/1 Kyiv (38) 10.1 11.3
1973 United States 3f NP (10) 10.3 10.8
1979 United States 103f NP (10) 2.0 2.0
1986 United States 7/1 Binghamton (15) 11.9 14.5
1986 United States 22/1 Binghamton (14) 17.0 20.0
1987 United States 47f Los Angeles (10) 9.6 9.1
1987 United States 21/1 Los Angeles (14) 16.8 20.2
1990 United States 9/1 Tennessee (16) 15.6 18.8
1988 USSR 1 Moscow (16) 20.7 23.8
1988 USSR 5 Baikalak (16) 10.9 12.3
1988 USSR 4 Irkutak (16) 18.3 20.0
1988 USSR 10 Novosibirak (16) 12.2 14.0
1988 USSR 4 Kachung (16) 9.7 10.8
1970 Vietnam 18f NP (10) 484.0 484.0
1970 Vietnam NP NP (10) 111.0 111.0
1973 Vietnam 3f South Vietnam (10) 140.3 140.0
1973 Vietnam 9f South Vietnam (10) 153.6 154.2
1986 Vietnam 2/1 Tan Uyen (14) 28.1 30.4
1986 Vietnam 2/1 Tan Uyen (14) 10.0 10.7
1986 Vietnam 2/1 Tan Uyen (14) 20.1 22.7
1986 Vietnam 3/1 Gan Gio (14) 13.8 14.9
1986 Vietnam 2/1 Long Xuyen (14) 7.3 8.3
1986 Vietnam 15/1 Ho Chi Minh (14) 22.4 25.0
1986 Vietnam 8/1 Ho Chi Minh (14) 16.8 19.6
1986 Vietnam 38/1 Ho Chi Minh (14) 19.2 22.0
1986 Vietnam 28/1 Hanoi (14) 9.3 10.7
1986 Vietnam 12/1 Song Be Province (14) 32.7 36.6
1990 Vietnam 4/1 Binh Long (16) 15.3 18.6
1990 Vietnam 5/1 Vung Tau (16) 22.7 27.8
1990 Vietnam 4/1 Tay Ninh (16) 28.5 35.1
1990 Vietnam 4/1 Song be Province (16) 12.6 14.8
1991 Vietnam 16f South (39) 16.2 18.1
1981 Yugoslavia 50/1 Zagreb (10) 20.1 22.4
1985 Yugoslavia 17/1 Zagreb (10) 19.0 21.8
1986 Yugoslavia 14/1 Krk (14) 12.5 13.6
1987 Yugoslavia 41/1 Zagreb (14) 12.1 13.3
Abbreviations: ?, unknown;  FRG, Federal Republic of Germany; NP, not provided; USSR, Union of Soviet Socialist Republics. Published data that included TEQ values are incorporated in
this table. Otherwise, we calculated dioxin TEQs using published concentration data and TEF values shown in Table 2. 
aThe number of women participating in the study (in many cases, the participants’ breast milk was combined, or pooled, to make a fewer number of samples; for example,10/1 repre-
sents 10 women who provided breast milk samples that were pooled to make one sample for analysis. bNorth Atlantic Treaty Organization, Committee on the Challanges of Modern
Society TEF values were used (40); these values are the same as the I-TEF values except for 1,2,3,4,6,7-heptaCDD, which is 0.1. This is not expected to result in substantially different TEQ
values from the I-TEF model. cA TEF of 0.5 was used for 2,3,7,8-pentaCDF. dArithmetic mean of duplicate analysis of pooled sample from 200 donors. eWeighted geometric mean of 100
samples. fMean value. gValues reported as means and ranges of congeners; mean values were used for this analysis. hTEQs were calculated using the Nordic TEF model, which differs
from the I-TEF model by assigning a value of 0.01 to 1,2,3,7,8-penta-CDF (14). iNordic TEFs were used to calculate TEQs (14). In this review of the published literature
on depuration of environmental chemicals
in breast milk, we describe the uncertainties
associated with the available information.
Our focus is on lipophilic environmental
chemicals, and each section below describes
the database for a particular chemical or
group of chemicals (studies are described in
chronological order). 
Dioxins/Furans
Fürst et al. (51) collected milk samples from
one mother for 1 year after the birth of her
second child and analyzed the samples for
dioxins and furans. The mother provided
breast milk samples during week 1, week 5,
weeks 10–13, and weeks 52–60 postpartum.
The analytical results are presented in Figures
7 (dioxins) and 8 (furans). OctaCDD is
reduced by approximately 50% between the
first and fifth weeks; the other congeners
decline by 15–30% (51). Fürst et al. (51) 
cautiously conclude that a strong mobilization of
… PCDDs and PCDFs takes place within the
ﬁrst few weeks after delivery.
In addition, 168 women provided breast milk
samples and information on the period of lac-
tation when the sample was collected. On
average, the levels of dioxins and furans in
mothers breast-feeding their second child (74
samples) were 20–30% lower than mothers
breast-feeding their ﬁrst child (79 samples).
Generally, Fürst et al. (51) found the greatest
decline for organochlorines, including PCBs
and pesticides, during the transition from
colostrum to ripe human milk (the authors
did not provide data for these chemicals).
In a study on fecal elimination of dioxins
and furans in a 3-month-old breast-fed
infant, four samples of breast milk were col-
lected from the mother (details on collec-
tion, such as sampling time, were not
provided) (52). A general decline in levels of
some of the congeners of dioxins and furans
over time are observable in Figures 9 and 10.
Hori (53) provided minimal information
on levels of dioxins and furans in breast milk
lipid from one mother 4–26 weeks after
delivery. No information on collection of
breast milk samples was provided. PCDDs
(TEQs, lipid basis) decreased from 29 ppt at
6 weeks to 21 ppt at 26 weeks, and PCDFs
decreased from 18 ppt at 6 weeks to 12 ppt
at 26 weeks (Figure 11). 
Schecter et al. (54) describe the results of
a study of dioxins and furans in the breast
milk of a somewhat less typical mother who
breast-fed one child for 16 months and then
breast-fed twins for over 2 years. The first
breast milk sample was collected in February
1992, after the mother had nursed her ﬁrst
child for about 1 year. The second sample
was collected in March 1993 (approximately
3 months after the birth of the twins), and
the last in September 1995. [Schecter et al.
(54) also provided data from March 1993 to
December 1993; however, these are averages
of 10 samples over that time period.] From
March 1993 to September 1995, the total
PCDDs, PCDFs, and PCDDs/PCDFs in
milk (TEQs, lipid basis) decreased by 70%,
66%, and 69%, respectively (Table 3).
Schecter et al. (55) postulated that the
increase in dioxins and furans between
December 1994 and September 1995 may
have been caused by a decrease in breast-
feeding and by a decreased intake of dioxins
from food. 
Abraham et al. (56,57) studied the intake
and fecal elimination of chemicals, including
dioxins and furans, in infants. Two samples
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Table 2. I-TEFs and the more recent WHO-TEFs
for dioxins and furans (41). 
I-TEF WHO-TEF
Dioxins
2,3,7,8-TCDD 1.0 1.0
1,2,3,7,8-PentaCDD 0.5 1.0
1,2,3,4,7,8-HexaCDD 0.1 0.1
1,2,3,6,7,8-HexaCDD 0.1 0.1
1,2,3,7,8,9-HexaCDD 0.1 0.1
1,2,3,4,6,7,8-HeptaCDD 0.01 0.01
1,2,3,4,6,7,8,9-OctaCDD 0.001 0.0001
Furans
2,3,7,8-TCDF 0.1 0.1
1,2,3,7,8-PentaCDF 0.05 0.05
2,3,4,7,8-PentaCDF 0.5 0.5
1,2,3,4,7,8-HexaCDF 0.1 0.1
1,2,3,6,7,8-HexaCDF 0.1 0.1
1,2,3,7,8,9-HexaCDF 0.1 0.1
2,3,4,6,7,8-HexaCDF 0.1 0.1
1,2,3,4,6,7,8-HeptaCDF 0.01 0.01
1,2,3,4,7,8,9-HeptaCDF 0.01 0.01
1,2,3,4,6,7,8,9-OctaCDF 0.001 0.0001
Abbreviations: CDD, chlorinated dibenzo-p-dioxin; CDF,
chlorinated dibenzofuran.
Figure 4. Trends in dioxin/furan concentrations in breast milk for all countries (ppt TEQ, lipid basis). Data
from Table 1.
Figure 5. Trends in dioxin/furan concentrations
(ppt TEQ, lipid basis) in breast milk for Germany,
Norway, the Netherlands, and Japan. Data from
Table 1. 
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Figure 6. Trends in dioxin/furan concentrations in
breast milk (ppt TEQ, lipid basis) for Western
Europe. Data from Table 1.
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1985 1975 1970 1980 1990 1995 2000of mother’s milk (at least 100 mL each) were
obtained by pumping empty the whole
breast. Reported results (Table 4) indicate
that for the dioxins, octaCDD and
heptaCDD appear to increase over the course
of 5 months, whereas the concentrations of
the remaining congeners stay relatively con-
stant (56). In contrast, the level of octaCDF
appears to decrease while the other furan
congeners remain essentially unchanged.
Abraham et al. (57) studied two breast-
fed infants (as well as one formula-fed infant,
which is not discussed here). Mother’s milk
(two samples during each sampling period)
was obtained by emptying the entire milk
content in the breast by pump. The levels
measured in the diet of two infants are not
shown here because, after the first month’s
measurements, the level of dioxins and furans
reported in their diets included those mea-
sured in foods other than breast milk, includ-
ing vegetables and rice pudding prepared
with cow’s milk.
In reviewing the above dioxin/furan
studies, it is clear that information reported
to date is not sufﬁcient to conﬁdently derive
depuration rates for dioxins and furans or to
make generalizations about the factors which
might inﬂuence elimination kinetics (Table
5). For example, the limited information on
breast milk sample collection methodologies
does not permit an evaluation as to whether
representative samples were obtained.
Further, there was only one woman included
in each study, with little information on
such factors as age and parity, and not all
studies examined depuration immediately
postpartum [for certain studies (52,56),
analysis of elimination kinetics was not the
intent of the research]. 
PCBs and Polybrominated
Biphenyls 
To assess whether levels of polybrominated
biphenyls changed in breast milk over time,
Brilliant et al. (58) studied one woman over
3 months, but they provided no information
on sampling methodology for this individual.
The authors noted day-to-day variations but
no trend in concentrations. 
A study to examine long-term excretion
of PCBs in mother’s milk was conducted with
a woman who was occupationally exposed to
PCBs (Kanechlor 300 and 500) through
work in a capacitor factory (59,60). Before
giving birth, the subject underwent 2 years of
fasting treatment for PCB intoxication. The
authors reported an approximately 76%
decrease in PCB levels in milk 16 months
after delivery and described a half-life of 8
months for PCBs in breast milk (breast milk
was used for study purposes only) (Figure 12). 
Hofvander et al (61) collected breast
milk samples from 18 mothers at 3 months
postpartum and from 23 other mothers at 6
months postpartum. The mean levels of
PCBs in the 3- and 6-month groups were
comparable. It is difficult to interpret the
results of this study because breast milk from
two separate groups of women was sampled
and only mean values were provided.
Mes and Lau (62) examined the change
in PCB levels in the milk of one woman
during the course of lactation. They reported
that despite ﬂuctuations, the PCB congener
content remained relatively constant in the
milk during lactation, except for those con-
geners with six and seven chlorine atoms in
the molecule. Mes and Lau (62) reported a
statistically significant increase in the hexa-
chlorobiphenyl content of the breast milk. 
Mes et al. (63) sampled breast milk from
16 women during eight intervals of a 98-day
lactation period. The milk samples were col-
lected over a 24-hr period. Data were
reported on a whole milk basis as averages of
all samples collected at a given time during
lactation; we used lipid levels to convert the
whole milk values to lipid-corrected values
(Table 6). Even after lipid correction, there
is no obvious trend in these data. 
Rogan and colleagues (64,65) studied
breast milk from the mothers of 856 chil-
dren and reported a decline in the PCB lev-
els, on average, by about 20% after 6
months (Table 7). The authors did not
describe breast milk sampling procedures.
Forty-three percent of the women were
primiparous, and the median time for
breast-feeding was 29 weeks. 
Fooken and Butte (66) collected breast
milk samples from ﬁve women and examined
variations in PCB levels during lactation.
Monthly samples were actually composed of a
mixture of weekly, manually collected breast
milk samples (equal volumes of samples from
one woman dating from the month of lacta-
tion were combined). The authors found
either no changes in residue level over time or
ﬂuctuations with no observable trends.
Galetin-Smith et al. (67) examined the
levels of PCBs in colostrum and milk samples
Children’s Health • LaKind et al.
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Figure 8. Concentrations of furan congeners (ppt,
lipid basis) in the breast milk of one woman up to
392 days postpartum. Data from Fürst et al. (51).
Figure 7. Log concentrations of dioxin congeners
(ppt, lipid basis) in the breast milk of one woman up
to 392 days postpartum. Data from Fürst et al. (51).
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Figure 9. Concentrations of dioxin congeners (ppt,
lipid basis) in breast milk of one woman up to 16
weeks pastpartum. Data from Jödicke et al. (52).
Figure 10. Concentrations of furan congeners
(ppt, lipid basis) in breast milk of one woman up to
16 weeks postpartum. Data from Jödicke et al.
(52). 
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from seven women. They provided no infor-
mation on collection methodology. PCB levels
were a summation of PCB congeners 28, 52,
101, 118, 138, 153, 170, and 180 from a 1:1
mixture of Arochlor 1254 and 1260. It was
difﬁcult to discern any common trend among
these women except for an increase in PCBs
from the colostrum samples to the ﬁrst milk
sample. However, the authors reported that
PCBs showed an increase of 6% per month. 
Hori (53) provided minimal information
on the levels of PCBs in breast milk lipid
from one mother 4–26 weeks after delivery.
No information on collection of breast milk
samples was provided. Coplanar PCBs
(TEQs, lipid basis) decreased from 50 ppt at
6 weeks to 32 ppt at 26 weeks (Figure 13). 
In a study on the intake and fecal elimina-
tion of chemicals in infants, Abraham et al.
(56) reported depuration data on three PCBs.
Two samples of a mother’s milk (at least 100
mL each) were obtained by pumping empty
the whole breast. The authors reported
increases in concentrations of PCB 138 and
PCB 180, but there was no obvious trend in
the data for PCB 153 (Table 8).
The research by Schecter et al. (55) on a
mother breast-feeding twins was described in
“Dioxins/Furans.” Schecter et al. (55) also
analyzed breast milk samples for PCB con-
geners. Concentrations of total PCBs are
shown in Table 9 (the concentrations of
individual PCB congeners detected in breast
milk lipid decreased from 52% to 95% over
the study duration). 
Kostyniak et al. (11) analyzed breast milk
samples from lactating female members and
spouses of male members of the New York
State Angler Cohort. The samples were ana-
lyzed for 77 PCB congeners and several pesti-
cides. Approximately half of the population
was primiparous, and the parity of the
remaining women was ≥ 2. Breast milk sam-
ples were collected after the second morning
feeding (hindmilk was collected). The study
was not longitudinal—in other words, the
authors did not analyze concentrations of
PCBs in breast milk over time for individual
women. However, they performed Spearman
rank correlations for the total months of lacta-
tion (over a lifetime) and the PCB concentra-
tions in breast milk fat for all 98 study
participants and reported negative correlation.
For primiparous women, Kostyniak et al. (11)
reported a signiﬁcant negative correlation for
total PCBs and ﬁve PCB congeners.
Information reported to date on depura-
tion of PCBs is not sufﬁcient to conﬁdently
derive depuration rates for this group of
chemicals or to make generalizations about
the factors that might inﬂuence elimination
Table 3. Concentrations of dioxins/furans in one mother’s breast milk over 3 years of lactation. 
Sampling date
Congener (ppt, lipid basis) Feb 1992a Mar 1993b Jul 1994 Dec 1994 Sep 1995
Dioxins
1,2,3,4,6,7,8,9-OctaCDD 147.0 201.4 72.2 85.9 126.3
1,2,3,4,6,7,8-HeptaCDD 38.0 59.1 13.5 14.6 30.2
1,2,3,4,7,8/
1,2,3,6,7,8-HexaCDD 29.0 35.7 9.3 10.4 12.4
1,2,3,7,8,9-HexaCDD 4.5 4.47 0.93 1.0 2.4
1,2,3,7,8-PentaCDD 4.8 5.2 1.0 1.1 1.7
2,3,7,8-TCDD 3.3 2.70 0.7 0.5 (0.4) ND
Furans
1,2,3,4,6,7,8,9-OctaCDF NA NP (0.59) ND (0.54) ND NP
1,2,3,4,7,8,9-HeptaCDF NA NP 0.21 0.16 NP
1,2,3,4,6,7,8-HeptaCDF 40.0 6.0 1.9 2.20 3.0
1,2,3,4,7,8/
1,2,3,6,7,8-HexaCDF 24.0 7.7 2.21 2.14 2.7
1,2,3,7,8,9-HexaCDF NA NP (0.1) ND (0.1) ND NP
2,3,4,6,7,8-HexaCDF 21.0 1.35 0.37 0.43 1.1
1,2,3,7,8-PentaCDF NA NP 0.13 0.10 NP
2,3,4,7,8-PentaCDF 4.4 4.8 0.79 0.68 1.6
2,3,7,8-TCDF 1.7 1.09 (0.52) (0.30) (0.5)
Abbreviations: NA, not available; NP, not provided; ND, not detected. Values shown in parentheses indicate the detec-
tion limit. Reprinted from Schecter et al. (54,55) with permission from Elsevier Science.
aBefore birth of twins. bThree months postpartum. 
Table 4. Concentrations (ppt, lipid basis) of dioxins/furans in one mother’s breast milk at 1 and 5 months
postpartum.
Month 1
Congener (ppt, lipid basis) Sample 1 Sample 2 Month 5
Dioxins
1,2,3,4,6,7,8,9-OctaCDD 60.38 66.75 84.66
1,2,3,4,6,7,8-HeptaCDD 14.15 15.10 18.47
1,2,3,6,7,8-HexaCDD 24.26 24.08 25.06
1,2,3,4,7,8-HexaCDD 2.42 2.35 2.14
1,2,3,7,8,9-HexaCDD 1.78 1.93 2.21
1,2,3,7,8-PentaCDD 7.95 7.39 7.82
2,3,7,8-TCDD 1.92 1.86 1.65
Furans
1,2,3,4,6,7,8,9-OctaCDF 5.30 4.93 1.51
1,2,3,4,6,7,8-HeptaCDF 5.81 6.18 5.41
1,2,3,4,7,8/
1,2,3,6,7,8-HexaCDF 7.08 7.68 8.98
2,3,4,6,7,8-HexaCDF 0.80 0.60 1.65
1,2,3,7,8-PentaCDF 0.28 0.29 0.33
2,3,4,7,8-PentaCDF 20.59 19.27 18.66
2,3,7,8-TCDF 0.90 1.05 0.42
Reprinted from Abraham et al. (56) with permission from Elsevier Science.
Figure 11. Concentration of dioxin and furan TEQs
in breast milk (ppt, lipid basis) from one mother
4–26 weeks after delivery. Data from Hori (53).
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Table 5. Synopsis of study data provided on parameters potentially inﬂuencing elimination kinetics of
dioxins/furans (presented in chronological order).
Breast milk Donor
No. of  Study duration sampling  age Supplementation
Study Women (postpartum) method (years) Parity information
Fürst et al. (51)1 1 –60 weeks NP NP 2 NP
Jödicke et al. (52)1 1 3 –16 weeks NP 28 NP NP
Hori (53)1 4 –26 weeks NP NP 1 NP
Schecter et al. (54) 1 Pre-a and 2 years NP 36 3 NP
Abraham et al. (56) 1 1 and 5 months Emptying NP NP Supplemented
whole breast at 5 months
NP, not provided. 
aMother breast-fed one child for 16 months and then breast-fed twins for 2 years.Children’s Health • LaKind et al.
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kinetics (Table 10). As with the dioxin/furan
studies, limited information on breast milk
sample collection methodologies does not
permit an evaluation as to whether represen-
tative samples were obtained. Pooling of
samples, small sample sizes, and minimal
data on such factors as age and parity further
limit our ability to quantify depuration. 
Chlorinated Organic Pesticides
Curley and Kimbrough (68) analyzed breast
milk samples from ﬁve women in one of the
ﬁrst explorations of organochlorine concen-
trations in breast milk at various times during
lactation and provided mean concentrations.
The mean total DDT concentrations
increased during lactation; this was not con-
sidered statistically significant because of a
large individual variation (68).
Bakken and Seip (69) analyzed colostrum
and breast milk from three women for hexa-
chlorobenzene (HCB), benzene hexachloride
(BHC), and total DDT for up to 9–16 weeks
postpartum. Wide ﬂuctuations were seen; in
one woman, BHC increased more than 4
times over the course of 4 days, from 8.6 to
40.8 ppb. The authors generally found the
highest concentrations in colostrum, with
declining values at later sampling times.
Bakken and Seip (69) did not indicate
whether breast milk was sampled in a way
that would account for diurnal variations or
for variability in lipid content (results were
on a whole milk basis).
De Bellini et al. (70) analyzed human
milk for organochlorine chemicals from 13
women over 30 days. They found increases
in p,p´-DDT and p,p´-DDE and decreases
in heptachlor epoxide, hexachlorocyclo-
hexane (HCH), and dieldrin (63,70). 
Yakushiji et al. (59) examined long-term
excretion of PCBs in mother’s milk. They
also examined p,p´-DDE, but provided no
data. However, the authors described a half-
life of 8 months for p,p´-DDE in breast
milk. 
Krauthacker et al. (71) determined con-
centrations of DDT and metabolites from 34
breast milk samples collected 3–5 days post-
partum and from 37 samples obtained at
later times (up to 55 weeks postpartum).
They provided no information on specific
sampling methodology, other than that
breast milk was manually expressed. Concen-
trations were given as means on a whole milk
basis. According to the authors, the ranges of
concentrations were large for samples col-
lected over the 55-week-period and over-
lapped completely. Krauthacker et al. (71)
concluded that the concentration of p,p´-
DDE at the beginning of lactation was not
significantly different from that from later
lactation periods.
Hofvander et al. (61) collected breast
milk samples from 18 mothers at 3 months
postpartum and from 23 other mothers at 6
months postpartum. The mean levels of
organochlorine compounds (DDT/metabo-
lites, HCB, HCH, and dieldrin) in the 3-
and 6-month groups were comparable. The
results of this study cannot be used to draw
conclusions about depuration because breast
milk from two separate groups of women
were sampled, introducing considerable
uncertainty.
Andersen and Orbék (72) studied
organochlorine levels in human breast milk
in Denmark; although data were not pro-
vided, the authors noted that the content of
HCB in milk fat declined slowly with the
time of postpartum sampling but that there
was no similar decline in levels of DDE,
DDT, dieldrin, or PCBs.
Mes et al. (63) sampled breast milk from
16 women during eight intervals of a 98-day
lactation period. The milk samples were col-
lected over a 24-hr period at different times
during each feeding, and if possible, from
alternating breasts. The authors reported the
following conclusions: a) a general downward
trend in residue concentrations in breast milk
was interrupted by sporadic increases; b) most
residues showed a statistically nonsigniﬁcant
increase in residue levels during the ﬁrst 30
days; and c) during lactation, a statistically
Figure 12. Depuration of PCBs from an occupa-
tionally exposed woman (ppm, lipid basis). Data
from Yakushiji et al. (59). 
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Table 6. Chlorinated hydrocarbon residues in whole breast milk samples from 16 women up to 98 days
postpartum. 
Days following parturition
PCB residue 7 14 28 42 56 70 84 98
ppb, whole milk 23.3  29.7 25.6 23.6 25.9 22.8 23.4 28.1
ppb, lipid basis 879.3 804.9 691.9 768.7 752.9 745.1 809.7 749.3
Percent fat 2.65 3.69 3.70 3.07 3.44 3.06 2.89 3.75
Reprinted from Mes et al. (63) with permission from Springer-Verlag.
Table 7. PCB concentrations in breast milk (ppm, lipid basis).
Sampling No. of breast Median PCB 95th percentile Maximum  Percent less than 
time milk samples level PCB level  PCB level  quantitation limit
Birth 733 1.77 3.91 16.00 13
6 weeks 617 1.53 3.44 14.80 6
3 months 498 1.46 3.35 15.00 9
6 months 362 1.38 2.90 17.10 12
9 months 62 1.18 2.70 3.20 6
1 year 101 1.17 2.34 2.54 11
18 months 32 1.02 2.55 3.28 16
Reprinted from Rogan et al. (65) with permission from the American Public Health Association (copyright 1986).
Figure 13. Concentrations of coplanar PCB TEQs
in breast milk (ppt, lipid basis) from one mother
4–26 weeks after delivery. Data from Hori (53).
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Table 8. Concentrations (ppb, lipid basis) of PCBs
in one mother’s breast milk at 1 and 5 months
postpartum.
Month 1
PCB Sample 1 Sample 2 Month 5
PCB 138 74 79 100
PCB 153 177 202 194
PCB 180 108 121 139
Reprinted from Abraham et al. (56) with permission from
Elsevier Science.
Table 9. Concentrations of total PCBs in one
mother’s breast milk over 2 years of lactation with
percent decrease (ppb, lipid basis) 
Sampling time Percent
3/93a 6/93 9/93 12/93 9/95 decrease
Total 285 172 156 80 63 78
PCBs
Reprinted from Schecter et al. (55) with permission from
Elsevier Science.
aThree months postpartum.Children’s Health • Infant exposure to chemicals in breast milk
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significant decrease was observed for HCB,
oxychlordane, transnonachlor, β -HCH, p,p´-
DDE, and p,p´-DDT. 
Rogan and and colleagues (64,65) stud-
ied breast milk from mothers of 865 children
and reported a decline in the levels of DDE,
on average, by about 20% after 6 months
(Table 11). Breast milk sampling procedures
were not described. 
Klein et al. (73) studied the elimination
kinetics of several organochlorine com-
pounds from day 2 to day 10 of breast-feed-
ing (30 volunteers). DDT was below the
level of detection in all samples. The authors
noted a rapid decrease in the DDE concen-
tration over time; the other chemicals, with
the exception of heptachlor, showed a linear
decrease over the study duration (Figure 14). 
Fooken and Butte (66) collected breast
milk samples from ﬁve women and examined
variations in organochlorine residue levels
(HCH, HCB, p,p´-DDT, and p,p´-DDE)
during lactation. Month-mix samples were
composed of breast milk samples that were
collected weekly. The authors found no
changes in residue level over time, and there
were no observable trends in the ﬂuctuations. 
Galetin-Smith et al. (67) examined the
levels of p,p´-DDT, o,p´-DDE, and p,p´-
DDE in colostrum and milk samples from
seven women. No information was provided
on collection methodology. The authors
reported a 3%/month decrease in levels of
p,p´-DDE during lactation, but noted that
this result was only marginally statistically
significant because individual variation was
pronounced. DDT increased 3%/month.
Greater variability would be anticipated in
these results because they were reported on a
whole milk, rather than a lipid, basis. 
Abraham et al. (56), in their study of the
intake and fecal elimination of chemicals in
infants, reported depuration data on HCB.
The authors obtained two samples of
mother’s milk (at least 100 mL each) at 1
month and 5 months postpartum by pump-
ing empty the whole breast. The HCB con-
centrations decreased by approximately 8%
over 5 months.
Schecter et al. (55) analyzed DDE and
HCB in the breast milk from a mother nurs-
ing twins. The authors reported a 92%
decrease in HCB in breast milk lipid over
approximately 30 months of lactation; DDE
in breast milk lipid declined by 81% during
the same time period. 
Information on depuration of organo-
chlorine pesticides is not sufficient to
confidently derive depuration rates for this
group of chemicals or make generalizations
Table 10. Synopsis of study data provided on parameters that potentially inﬂuence elimination kinetics of PCBs and/or chlorinated organic pesticides (COPs) (pre-
sented in chronological order).
Study/ No. of  Study Donor Supplementation
chemical group women duration Breast milk sampling method  age (years) Parity information
Curley and Kimbrough (68)  5 3–96 days Manual expression 20–33 1–4 NP
COP postpartum
Bakken and Seip (69) 3 Over 3–12 days; NP NP NP NP
COP time postpartum 
not provided
De Bellini et al. (70) 13 6–30  days NP 20–39 >  1 NP
COP postpartum
Brilliant et al. (58)  1 Over 3 months; Manual expression NP NP NP
PCB time postpartum 
not provided
Yakushiji et al. (59)  1 16 months NP 36 1 Milk expressed for 
PCB, COP postpartum study purposes only
Krauthacker et al. (71)  25 3–5 days to 55 Manual 18–32 NP NP
COP (37 samples) weeks postpartum expression
Hofvander et al. (61)  18 and 23  At 3 or 6 months Nipple cleaning, complete  21–35 NP NP
PCB, COP (2 groups) postpartum milk extraction with electric 
pump from one or both breasts 
Andersen and Orbék (72)  57 4–113 days  24-hr representative NP NP NP
COP postpartum samples, either fore- or 
hindmilk or mixture
Mes and Lau (62) 1 98  days NP NP NP NP
PCB postpartum
Mes et al. (63)  16 98 days Manually expressed; 24-hr  Mean = 35 NP NP
PCB, COP  postpartum  representative sample, alternate 
between breasts and before 
and after feedings, if possible
Rogan et al. (65)  807 Up to 18 months NP 16–41 1 (43%) NP
PCB, COP postpartum
Klein et al. (73) 39 2–10  days NP NP NP NP
COP postpartum
Fooken and Butte (66)  5 Up to 5 and 9  Manual expression 23–36 1 or 2 NP
PCB, COP months postpartum
Galetin-Smith et al. (67) 7 Up to 8 months  NP NP NP Diluted lemon juice
PCB, COP postpartum
Hori (53) 1 4–26  weeks NP NP 1 NP 
PCB postpartum
Abraham et al. (56)  1 1 and 5 months Emptying whole breast NP NP Supplementation 
PCB, COP postpartum by 5 months with 
vegetable pap
Schecter et al. (55)  1 Pre- and 2 years NP NP 3 NP
PCB, COP postpartum
Kostyniak et al. (11)  98 Not  Express 2 oz milk after second  NP 1, > 2 NP
PCB longitudinal morning feeding, either manually 
or with a pump
NP, not provided.about the factors that might inﬂuence elimi-
nation kinetics (Table 10). An additional
complication involves comparing different
classes of chemicals. As stated above, limited
information on breast milk sample collection
methodologies does not permit an evaluation
as to whether representative samples were
obtained. Pooling of samples, small sample
sizes, and minimal data on factors such as age
and parity further limit our ability to quantify
depuration. 
In summary, several factors could poten-
tially influence reported depuration rates.
These include the number of previous chil-
dren nursed, initial body burden of the
mother, diet, sampling methodology,
amount of lipid in breast milk, and the
amount of milk consumed by the infant.
There are, at present, insufficient existing
data to explore whether these factors play a
role in rates of depuration. Without this type
of information, the discrepancies in the
reported rates of depuration cannot be
resolved. Thus, the available information
supports the inclusion of depuration when
estimating infant exposure to environmental
chemicals from breast milk, but the data do
not support the selection of a speciﬁc rate of
depuration.
Conclusions
Environmental chemicals in human milk
have been studied since the 1950s, when the
pesticide DDT was first detected in breast
milk (1). These studies are the main source
of information with which to estimate health
beneﬁts and risks to an infant who is breast-
fed rather than formula-fed. Each of these
studies has strengths and weaknesses; taken
individually, many provide snapshots of con-
centrations of environmental chemicals in
the breast milk of a small population at one
time and place. It is difﬁcult to make widely
applicable statements about levels of envi-
ronmental chemicals in breast milk from
these studies because of a lack of consistent
sampling methodologies and reporting of
the results. 
Although most experts in the fields of
pediatric health and lactation agree that,
except in unusual situations, breast-feeding is
the preferred nutrition for infants, a better
understanding of an infant’s level of exposure
to environmental chemicals is essential, par-
ticularly in the United States where there is
relatively little information. Considering
both the levels of chemicals in breast milk of
women residing in the United States and the
kinetics of elimination of those chemicals
during lactation, existing data are extremely
limited. Shortcomings of published studies
include inconsistent sampling and analysis
protocols, incomplete reporting of sampling
methods, nonrepresentative sampling (geo-
graphic, parity, age), duration of sampling,
limited number of study participants, and
the number and types of chemicals analyzed.
These limitations restrict our ability to
predict infant body burdens, particularly
during the early days and weeks of lactation.
A carefully planned and executed program of
breast milk sampling and analysis would
serve to provide the information needed to
assess infant exposures during breast-feeding
and to provide consistent and scientifically
sound information on benefits and risks of
breast-feeding in the United States.
Increased sampling of breast milk is nec-
essary to provide a better basis for character-
izing the levels of chemicals in breast milk;
therefore, a program should be initiated in
the United States to sample and analyze
breast milk. This type of program would
provide information on current levels of
environmental chemicals in breast milk and
enable the development of a scientifically
based and consistent message to interested
parties (e.g., doctors, nurses, lactation
specialists, and new mothers) on the risks
and beneﬁts of breast-feeding. 
The objectives and goals of a breast milk
monitoring program for women in the
United States are as follows: 
• Information should be obtained on women
from diverse geographic regions of the
United States and from different socioeco-
nomic and demographic backgrounds. For
example, the United States could be divided
into four compartments: Northeast,
Southeast, Northwest, and Southwest.
Samples should be collected from both rural
and urban locations.
• Previous studies should be extended by
testing for an increased number of environ-
mental chemicals in breast milk. In addi-
tion to the chemicals discussed in this
paper, analytes should include certain
heavy metals as well as other chemicals
with significant lipid solubility and long
biological half-life. 
•Longitudinal information should be
obtained during the course of lactation so
that the decrease in concentration of the
chemical over time can be assessed.
Lactating women should be enrolled in the
study on a longitudinal basis, donating
samples on a monthly basis (or more fre-
quently in the first 2 months) and then
every 2–3 months if lactation continues.
Recruitment of participants may be aided
by lactation consultants.
• Harmonization of sampling and analysis
protocols should be promoted to improve
the comparability of the results. Studies
should include harmonized sampling and
analysis protocols, such as protocols for col-
lecting breast milk samples, gathering infor-
mation on study participants relevant to the
study (e.g., mother’s smoking status, age,
parity, dietary information, occupational
exposure information, infant dietary supple-
mentation), reporting of breast milk data,
and reporting of methodologic information. 
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